Embla Medical hf (OSSFF) Ratios
Embla Medical hf Ratios
OSSFF's free cash flow for Q3 2026 was $33.44M. For the 2026 fiscal year, OSSFF's free cash flow was decreased by $-4.87M and operating cash flow was $38.31M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.48 | 1.92 | 1.47 | 1.71 | 2.22 |
| Quick Ratio | 0.94 | 1.22 | 0.91 | 1.15 | 1.58 |
| Cash Ratio | 0.33 | 0.37 | 0.32 | 0.46 | 0.69 |
| Solvency Ratio | 0.18 | 0.16 | 0.09 | 0.14 | 0.05 |
| Operating Cash Flow Ratio | 0.46 | 0.48 | 0.26 | 0.54 | 0.63 |
| Short-Term Operating Cash Flow Coverage | 2.10 | 2.18 | 0.70 | 1.49 | 2.61 |
| Net Current Asset Value | $ -391.71M | $ -304.70M | $ -341.00M | $ -302.09M | $ -310.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.34 | 0.36 | 0.36 | 0.40 |
| Debt-to-Equity Ratio | 0.61 | 0.67 | 0.76 | 0.72 | 0.84 |
| Debt-to-Capital Ratio | 0.38 | 0.40 | 0.43 | 0.42 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.38 | 0.38 | 0.38 | 0.44 |
| Financial Leverage Ratio | 1.96 | 1.97 | 2.08 | 2.01 | 2.12 |
| Debt Service Coverage Ratio | 1.84 | 2.07 | 0.78 | 1.28 | 1.60 |
| Interest Coverage Ratio | 5.91 | 4.98 | 5.99 | 9.76 | 5.54 |
| Debt to Market Cap | 0.17 | 0.27 | 0.24 | 0.16 | 0.14 |
| Interest Debt Per Share | 1.32 | 1.16 | 1.18 | 1.08 | 1.17 |
| Net Debt to EBITDA | 2.31 | 2.75 | 4.52 | 3.03 | 4.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.18% | 60.77% | 61.19% | 63.37% | 62.15% |
| EBIT Margin | 13.18% | 11.76% | 9.38% | 13.31% | 8.46% |
| EBITDA Margin | 19.71% | 18.01% | 12.45% | 16.68% | 12.23% |
| Operating Profit Margin | 13.43% | 11.19% | 9.34% | 13.31% | 8.46% |
| Pretax Profit Margin | 11.62% | 9.51% | 7.82% | 12.06% | 2.02% |
| Net Profit Margin | 8.97% | 7.31% | 5.92% | 8.90% | 0.99% |
| Continuous Operations Profit Margin | 9.01% | 7.36% | 6.01% | 9.14% | 0.99% |
| Net Income Per EBT | 77.21% | 76.82% | 75.68% | 73.86% | 48.85% |
| EBT Per EBIT | 86.56% | 85.03% | 83.67% | 90.60% | 23.88% |
| Return on Assets (ROA) | 4.96% | 4.21% | 3.21% | 5.13% | 0.51% |
| Return on Equity (ROE) | 9.73% | 8.32% | 6.69% | 10.30% | 1.09% |
| Return on Capital Employed (ROCE) | 9.02% | 7.51% | 6.17% | 9.02% | 4.99% |
| Return on Invested Capital (ROIC) | 6.56% | 5.61% | 4.39% | 6.43% | 3.01% |
| Return on Tangible Assets | 10.78% | 9.28% | 7.29% | 11.77% | 1.15% |
| Earnings Yield | 3.97% | 3.43% | 2.11% | 2.34% | 0.19% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.29 | 5.29 | 5.48 | 5.95 | 5.04 |
| Payables Turnover | 12.30 | 9.76 | 9.73 | 9.85 | 11.90 |
| Inventory Turnover | 2.44 | 2.20 | 2.11 | 2.53 | 2.56 |
| Fixed Asset Turnover | 3.98 | 4.29 | 4.01 | 3.95 | 3.67 |
| Asset Turnover | 0.55 | 0.58 | 0.54 | 0.58 | 0.52 |
| Working Capital Turnover Ratio | 5.74 | 5.48 | 5.90 | 4.62 | 3.64 |
| Cash Conversion Cycle | 178.04 | 197.27 | 202.07 | 168.42 | 184.53 |
| Days of Sales Outstanding | 58.03 | 68.99 | 66.65 | 61.30 | 72.39 |
| Days of Inventory Outstanding | 149.68 | 165.68 | 172.92 | 144.16 | 142.82 |
| Days of Payables Outstanding | 29.67 | 37.40 | 37.50 | 37.04 | 30.67 |
| Operating Cycle | 207.71 | 234.67 | 239.57 | 205.46 | 215.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.33 | 0.22 | 0.15 | 0.24 | 0.22 |
| Free Cash Flow Per Share | 0.28 | 0.12 | 0.08 | 0.17 | 0.16 |
| Dividend Paid and CapEx Coverage Ratio | 6.19 | 2.23 | 2.34 | 3.77 | 2.77 |
| Capital Expenditure Coverage Ratio | 6.19 | 2.23 | 2.34 | 3.77 | 3.84 |
| Operating Cash Flow Coverage Ratio | 0.26 | 0.20 | 0.13 | 0.22 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.12 | 0.08 | 0.14 | 0.15 |
| Free Cash Flow Yield | 5.46% | 3.05% | 1.73% | 2.71% | 2.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.50 | 29.18 | 47.31 | 42.65 | 538.66 |
| Price-to-Sales (P/S) Ratio | 2.26 | 2.13 | 2.80 | 3.80 | 5.32 |
| Price-to-Book (P/B) Ratio | 2.45 | 2.43 | 3.16 | 4.39 | 5.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 18.31 | 32.74 | 57.75 | 36.96 | 49.07 |
| Price-to-Operating Cash Flow Ratio | 15.35 | 18.07 | 33.10 | 27.15 | 36.29 |
| Price-to-Earnings Growth (PEG) Ratio | 1.02 | 0.73 | -1.42 | 0.05 | -5.93 |
| Enterprise Value Multiple | 13.78 | 14.59 | 27.00 | 25.80 | 48.41 |
| Enterprise Value | 2.62B | 2.10B | 2.42B | 3.09B | 3.73B |
| EV to EBITDA | 13.78 | 14.59 | 27.00 | 25.80 | 48.41 |
| EV to Sales | 2.72 | 2.63 | 3.36 | 4.30 | 5.92 |
| EV to Free Cash Flow | 22.00 | 40.33 | 69.35 | 41.88 | 54.65 |
| EV to Operating Cash Flow | 18.45 | 22.25 | 39.75 | 30.76 | 40.42 |
| Tangible Book Value Per Share | -0.11 | -0.12 | -0.26 | -0.18 | -0.22 |
| Shareholders’ Equity Per Share | 2.08 | 1.67 | 1.52 | 1.47 | 1.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.23 | 0.23 | 0.24 | 0.38 |
| Revenue Per Share | 2.26 | 1.90 | 1.72 | 1.70 | 1.49 |
| Net Income Per Share | 0.20 | 0.14 | 0.10 | 0.15 | 0.01 |
| Tax Burden | 0.77 | 0.77 | 0.76 | 0.74 | 0.49 |
| Interest Burden | 0.88 | 0.81 | 0.83 | 0.91 | 0.24 |
| Research & Development to Revenue | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 |
| SG&A to Revenue | 0.42 | 0.08 | 0.10 | 0.10 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.64 | 1.06 | 0.94 | 1.03 | 3.26 |
Currency in USD